Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi in Europe and South Africa

Sep 27, 2023

Mumbai (Maharashtra) [India]/ Dublin [Ireland], September 27: Cosmo Pharmaceuticals N.V. (SIX: COPN) (XETRA: C43) ('Cosmo') and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd....

Hikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in the US

Aug 31, 2022

London [UK]/ Mahwah (New Jersey) [US], Mumbai (Maharashtra) [India], August 31 (ANI/PRNewswire): Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, and Glenmark Specialty...

Glenmark gets US drug regulator's nod for high BP medicine

Dec 19, 2022

Glenmark's Nicardipine Hydrochloride capsules of 20 mg and 30 mg will be distributed in the US by Glenmark Pharmaceuticals US, according to a statement...

Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%

Sep 21, 2021

Mumbai (Maharashtra) [India], September 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S....

Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023-24

Feb 15, 2024

Mumbai (Maharashtra) [India], February 15: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical Company, today announced its financial results for the third quarter ended...

Glenmark Pharma reports consolidated revenue growth of 6.3 per cent and adjusted EBITDA growth of 8.3 per cent YoY for Q2 FY 2023-24

Nov 11, 2023

Mumbai (Maharashtra) [India], November 11: Glenmark Pharmaceuticals Ltd. (Glenmark), a research led, global pharmaceutical company, today announced its financial results for the second quarter...